Impact Factor
3.07
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.10
5,611 total citations
h5-index
90
h5 depth signal
Cited share
18.2%
964 of 5,285
Total citations
5,611
Citation footprint
Metric signal
1.39
External metric anchor
Self-citation
5.1%
288 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
13,683
Germany
2,703
United Kingdom
2,491
Canada
1,592
Italy
1,122
Citing Fields of Research
Brain Imaging
13,863
Brain Neurological Disorders
7,789
Oncology
6,811
Cancer & Development
4,156
Immunology
2,738
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
29,654
Articles tracked across the journal lifetime
Indexed publication set
5,285
964 cited publications
Last 12 months
2,957
246.4 publications/month
Open access share
3.5%
104 OA publications in the last year
Leading citing country
United States
13,683 citing publications
Leading citing field
Brain Imaging
13,863 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 1999-
v1n1, Jan. 1999-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Brain Imaging
Issuing & Sponsoring Bodies
Contributor
Society for Neuro-Oncology
Broad Categories
Neoplasms
Neurology
Brain Imaging
MeSH Descriptors
Brain Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/neuonc/noag264
Open DOI
A Trifecta of Combining innate and adaptive checkpoint blockade
02
03
DOI 10.1093/neuonc/noag238
Open DOI
Biomarker-guided treatment strategies for patients with gliomas in clinical practice
Targeted therapy has made important contributions to improving outcomes for patients with many solid tumors, but has had only limited activity so far in patients with gliomas, notably glioblastoma. Failure of targeted therapy in glioblas...
04
DOI 10.1093/neuonc/noag258
Open DOI
Routing to the seizure in postoperative human glioma cortex: spatio-temporal uncoupling between slow and fast extracellular neuronal activities
Background: Diffuse gliomas are frequently associated with epilepsy, particularly in low-grade variants. Seizures are key events to be considered in glioma management, including during surgery. Optimizing resection of epileptic areas may...
05
DOI 10.1093/neuonc/noag263
Open DOI
Finding a new strategy to defeat an old foe: Overcoming radioresistance in glioblastoma
06
DOI 10.1093/neuonc/noag262
Open DOI
Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant Glioma
Background: Contrast enhancement is generally considered an adverse prognostic feature in adult glioma. However, its significance in newly diagnosed grade 2 IDH-mutant glioma remains uncertain, with important implications for use of the ...
07
DOI 10.1093/neuonc/noag261
Open DOI
Unilateral vs Bilateral Hippocampal Avoidance During WBRT With Memantine for Brain Metastases: A Randomized Single-Blind Phase 2 Clinical Trial
Background: Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) with memantine reduces, but does not eliminate, cognitive decline. Left hippocampal dose may be more closely associated with cognitive outcomes. We investigated whether...
08
09
DOI 10.1093/neuonc/noag168
Open DOI
Hijacking developmental immunity: Inflammation and immune dysregulation in pediatric brain tumors
Pediatric brain tumors (PBTs) remain a leading cause of cancer-related mortality in children, underscoring the need for more effective therapeutic strategies. These tumors arise from disrupted neurodevelopmental programs and evolve withi...
10
DOI 10.1093/neuonc/noag257
Open DOI
AI in Neuro-Oncology: An Overarching Review
Artificial intelligence (AI) is increasingly being applied across neuro-oncology domains to analyze complex, high-dimensional, multimodal data. Despite major advances in the biological understanding and classification of CNS tumors, clin...
Bibliographical & Catalog Notes
Description based on: Vol. 1, issue 4 (Oct. 1999).
Some v. supplemented by "abstract issues".
Also issued online.
v. 1, no. 1 (Jan. 1999)20001127 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper